Skip to main content

Table 5 Cytoplasmic REDD1 expression and DFS

From: Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma

REDD1 expression No. of patients Median survival months (95% CI) Survival rate (95% CI) χ 2 P-value
36-months 60-months 120-months
Low expression 148 103.200(76.880,129.520) 0.76(0.671,0.828) 0.60(0.495,0.690) 0.27(0.161,0.391) 60.873 < 0.001
High expression 81 20.000(15.954,24.046) 0.41(0.292,0.524) 0 0